Skip to main content
SpringerLink
Log in

Genotypic characterization of HPV serotypes in cervical samples from Indian women: a multi centric study

  • Original Article
  • Published:
VirusDisease Aims and scope Submit manuscript

Abstract

Human papilloma virus (HPV infection) plays a important role in causing cervical cancer. Out of 184 different HPV genotypes, 40 diverse types only can cause anogenital infection. HPV present in >99% of cervical cancers with high risk types (16, 18) associated with cancer and Low risk types (6, 11) are associated with genital warts. Aim of the study is to determine the epidemiology of HPV infection in Indian women’s population. Three hundred and thirty four liquid based cytology (LBC) samples were collected across India from the different age groups of Indian women. Pap smear, PCR and gene sequencing tests were performed for the collected LBC samples. Low risk serotype 6 (16.7%) were detected compared to other high risk serotypes. Majority of positive cases were observed in the age group between 19 and 39 groups. Northern part of India contributes high (7.1%) in HPV infection compared to other regions of India. Reports from these studies covered few regions of India showing a wide range in the prevalence of HPV infection and serotype distribution due to diversified socio economic and geo climatic conditions. This study aims to identify the epidemiology of HPV in the Indian population and concludes that early and periodic screening of women for HPV can avoid the risk of cervical cancer at the early stage of infection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Gustavo Stephan. Cervical cancer Elimination Initiative. www.who.int/initiatives/cervical-cancer-elimination-initiative (2018)

  2. Arbyn M, Weiderpass E, Bruni L, de Sanjosé S, Saraiya M, Ferlay J, Bray F. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health. 2020;8(2):191–203.

    Article  Google Scholar 

  3. Egawa N, Doorbar J. The low-risk papillomaviruses. Virus Res. 2017;231:119–27.

    Article  CAS  PubMed  Google Scholar 

  4. Danielewski JA, Garland SM, McCloskey J, Hillman RJ, Tabrizi SN. Human papillomavirus type 6 and 11 genetic variants found in 71 oral and anogenital epithelial samples from Australia. PLoS ONE. 2015;8(5):e63892.

    Article  Google Scholar 

  5. Eileen M. Burd human papillomavirus and cervical cancer. Clin Microbiol Rev. 2013;16:1–17.

    Google Scholar 

  6. Nejo YT, Olaleye DO, Odaibo GN. Molecular characterisation of genital human papillomavirus among women in Southwestern, Nigeria. PLoS ONE. 2019;14(11):e0224748.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Kadian LK, Singhal G, Sharma S, Chauhan P, Nanda S, Yadav R. Incidence and association of HPV16 and 18 with various risk factors in cervical cancer patients in population of Haryana Region, India. J Clin Diagn Res. 2019; 13(2).

  8. De Martel C, Georges D, Bray F, Ferlay J, Clifford GM. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. Lancet Glob Health. 2020;8(2):180–90.

    Article  Google Scholar 

  9. MeMeites E, Gee J, Unger E, Markowitz L. Human Papilloma Virüs. Centers for disease control and prevention (CDC). [Erişim tarihi: October 2020]. Erişim adresi: Pinkbook| HPV| Epidemiology of Vaccine Preventable Diseases| CDC. 2020.

  10. Chan CK, Aimegambetova G, Ukybassova T, Kongrtay K, Azizan A. Human papillomavirus infection and cervical cancer: epidemiology, screening, and vaccination—review of current perspectives. J Oncol. 2019; 10

  11. Chen Z, Jing Y, Wen Q, Ding X, Zhang S, Wang T, Zhang Y, Zhang J. L1 and L2 gene polymorphisms in HPV-58 and HPV-33: implications for vaccine design and diagnosis. Virology Journal. 2016 Dec;13:1-2.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Hull R, Mbele M, Makhafola T, Hicks C, Wang SW, Reis RM, Mehrota R, Mkhize-Kwitshana Z, Kibiki G, Bates DO, Dlamini Z. Cervical cancer in low and middle-income countries. Oncol Lett. 2020;20:2058–74.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Kapoor CS, Sharma M. Prevalence of HPV infection in reproductive aged female in Delhi NCR region. Clin Epidemiol Global Health. 2020;8:612–5.

    Article  Google Scholar 

  14. Saxena V, Pai V, Rajagopal, Mehnaz A. Molecular detection of human papillomavirus (HPV) in females and assessment of risk factors for HPV infection: a study from Coastal Karnataka. J Clin Diagn Res. 2020;12(6):46–50.

    Google Scholar 

  15. Senapati R, Nayak B, Kar SK, Dwibedi B. HPV Genotypes distribution in Indian women with and without cervical carcinoma: Implication for HPV vaccination program in Odisha, Eastern India. BMC Infect Dis. 2017;17(1):30.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Nayar R, Wilbur DC. The Bethesda system for reporting cervical cytology: a historical perspective. Acta Cytol. 2017;61(4–5):359–72.

    Article  PubMed  Google Scholar 

  17. Devi KU, Reineke A, Reddy NN, Rao CU, Padmavathi J. Genetic diversity, reproductive biology, and speciation in the entomopathogenic fungus Beauveria bassiana (Balsamo) Vuillemin. Genome. 2006;49(5):495–504.

    Article  CAS  PubMed  Google Scholar 

  18. Neelapu NR, Reineke A, Chanchala UM, Koduru UD. Molecular phylogeny of asexual entomopathogenic fungi with special reference to Beauveria bassiana and Nomuraea rileyi. Rev Iberoam Micol. 2009;26(2):129–45.

    Article  PubMed  Google Scholar 

  19. Bruni L, Albero G, Serrano B, Mena M, Collado JJ, Gómez D, Muñoz J, Bosch FX, de Sanjosé S. ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre).

  20. Bruni L, Albero G, Serrano B, Mena M, Gómez D, Muñoz J. Human papillomavirus and related diseases in India. Summary report 17 June 2019. ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre).

  21. Krings A, Dunyo P, Pesic A, Tetteh S, Hansen B, Gedzah I, Wormenor CM, Amuah JE, Behnke AL, Höfler D, Pawlita M. Characterization of Human Papillomavirus prevalence and risk factors to guide cervical cancer screening in the North Tongu District, Ghana. PLoS One. 2019 Jun 27;14(6):e0218762.

  22. Braaten KP, Laufer MR. Human papillomavirus (HPV), HPV-related disease, and the HPV vaccine. Rev Obstet Gynecol. 2008;1(1):2.

    PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors are thankful to LifeCell International private limited for providing the research facilities.

Author information

Authors and Affiliations

  1. Center for Drug Discovery and Development, Sathyabama Institute of Science and Technology, Chennai, Tamil Nadu, 600119, India

    Ganesh Kumar Sarvesan & Krupakar Parthasarathy

  2. LifeCell International Pvt. Ltd, Chennai, 600127, India

    Chirayu Padhiar

  3. Centre for Genomics and Immunomics, VivagenDx Labs, Chennai, 600042, India

    HariBalaji V

Authors
  1. Ganesh Kumar Sarvesan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Krupakar Parthasarathy
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chirayu Padhiar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. HariBalaji V
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Krupakar Parthasarathy.

Ethics declarations

Conflict of interest

All three authors declared that they have no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sarvesan, G.K., Parthasarathy, K., Padhiar, C. et al. Genotypic characterization of HPV serotypes in cervical samples from Indian women: a multi centric study. VirusDis. 34, 395–401 (2023). https://doi.org/10.1007/s13337-023-00838-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13337-023-00838-7

Keywords

Search

Navigation